drugset / Trial / NCT00338481

"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer

NCT00338481 ↗

Phase 4 Completed 20 enrolled Sankt Lukas Hospice
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to test whether "red morphine drops" applied in the mouth are superior to an equivalent amount of morphine applied as subcutaneous injection for the relief of breathlessness in terminal patients suffering from primary lung cancer or lung metastases.

Timeline

Start
2006-04
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified 14.4 mg Oral
Comparator Morphine Other / unclassified 24 mg Oral

Indications